The Decision Lab

In a world of converging crises, learn how your company can manage the rise of cyber risk with scenario-planning.

From the time we are children, we are told to listen to experts. These figures of authority usually begin as our parents, but as we grow up, they become teachers, industry experts, scientists and policy makers. When we are unsure of how to behave, we look to experts to nudge us in the right direction.

In early 2020, the world was struck by a pandemic that brought daily life to a screeching halt. Among all the tragedy and the trauma brought on by COVID-19, many people found themselves searching for a silver lining.

The link between behavioral science and the stock market is always relevant, but the conversation surrounding it becomes increasingly important in times of uncertainty, as seen in the early stages of the coronavirus pandemic.

The frayed relationship people are beginning to have with science and scientists means that the field needs to come up with new ways to try and get people to trust their findings.

The COVID-era ushers in a unique set of needs posed by our major changes in lifestyle, and brings to light prominent cracks within existing systems.

Pharmaceutical companies also need to understand what motivates human behavior in order to best market their products in a manner that will encourage people to fulfill their course-of-action.

We take a deeper look at what motivates us to be charitable, and how an understanding of our cognitive processes can push us towards charitable behaviors.

Effective transport systems require more than just high functioning machines; they require an understanding of human drives and behavioral patterns.